Loading clinical trials...

Safety and Effectiveness of Ticagrelor in Patients Undergoing Carotid Stenting | Clinical Trials | Clareo Health

UNKNOWNPHASE1

Safety and Effectiveness of Ticagrelor in Patients Undergoing Carotid Stenting

NCT04091074•Assiut University

Summary

patients undergoing carotid stenting take dual anti platelet therapy to prevent thrombotic complications usually used drugs are aspirin plus clopidogrel but there are patients not respond so ticagrelor may be an effective and safe alternative

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•1. Ischemis stroke of both sex.
•2. More than 18 years.
•3. Accepting all study requirements.

Exclusion Criteria

•1. Refuse to comply with all study requirements.
•2. bleeding tendency or liver diseases

Key Dates

Start Date

January 1, 2022

Primary Completion Date

December 1, 2022

Completion Date

December 1, 2022

Last Updated

March 23, 2021

Enrollment

ESTIMATED participants

Conditions

Carotid Stenosis

Interventions

Ticagrelor

DRUG

Clopidogrel

DRUG

Carotid stenting

PROCEDURE

Remote Ischemic Conditioning Plus Stenting for Symptomatic Carotid Artery Stenosis

NCT07412249

Carotid Stenosis

View study

RECRUITING

Residual Stenosis and Restenosis Following Carotid Endarterectomy With Primary Closure, A Prospective Tracking Study

NCT07057297

Carotid ArteriosclerosisCarotid Stenosis+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 23, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Safety and Effectiveness of Ticagrelor in Patients Undergoing Carotid Stenting

Inclusion Criteria

Exclusion Criteria

Remote Ischemic Conditioning Plus Stenting for Symptomatic Carotid Artery Stenosis

Residual Stenosis and Restenosis Following Carotid Endarterectomy With Primary Closure, A Prospective Tracking Study

Comprehensive Assessment of Atherosclerotic Ischemic Stroke Risk and Development of a Prediction Model

Direct Access Carotid Artery Stenting Using the Neuroguard IEP System (PERFORMANCE III)

Cognitive Improvement After Carotid Stenting in Hyperbaric Oxygen Therapy Trial

Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions, Cardiovascular Atherosclerosis, Syndrome With Abnormal Immune Activation and sarcoïdosis